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The Effect of Dust Mite extract on Esophageal Tight Junctions in 
Eosinophilic Esophagitis 
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Advisor: Samantha Simet, PhD 
Eosinophilic Esophagitis (EE) is a chronic inflammatory disease that effects individuals of all ages. 
EE is mediated by an allergen response, causing the release of thymic stromal lymphopoietin 
(TSLP), and subsequent inflammation and eosinophil migration and infiltration of the esophagus 
through the activation of the JAK/STAT pathway and CD4+ T-cells. EE has typically been 
associated with food allergies, but studies have shown that aeroallergens can cause EE as well. 
Current treatments of EE have primarily focused on nonspecific methods, though anti-TSLP is 
beginning to be tested as a possible treatment for EE. The aim of this study was to see how 
house dust mites affected tight junction function in esophageal cells and determine if 
application of anti-TSLP will prevent dust mite’s effects. This was accomplished through a 
transwell cell culture model. Dust mites along with experimental conditions Gö 6976, interferon-
gamma, eosinophils, and TSLP synthetic peptide (anti-TSLP) was used to determine how these 
conditions affected esophageal cell tight junctions. Transepithelial electrical resistance (TEER) 
was recorded to measure epithelial integrity. Cells were analyzed through Prism and imaged by 
immunofluorescence staining. Results showed that dust mites caused a decrease in epithelial 
resistance through a 24-hour period. Interactions between eosinophils and dust mites caused 
further decreases in epithelium resistance. When esophageal cells are treated with anti-TSLP, 
the addition of dust mites did not cause a fall in electrical resistance; however, it did not stop 
eosinophils disruption of epithelial resistance. Immunofluorescence was used to show changes 
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in tight junction function for each condition.  These findings indicate that dust mites do affect 
esophageal cell function and anti-TSLP negates the disruptive actions of dust mites. Further 
studies have to be conducted to understand aeroallergens role in EE and how treatments can be 
tailored for aeroallergens. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
 
List of Figures 
Fig. 1:            2 
Histology of normal esophagus and EE. A. Normal histology of the esophagus. B. EE biopsy 
showing infiltration of eosinophils in the epithelium. C. Shows superficial layering of surface 
eosinophils through black arrow. D. An example of an eosinophilic microabscess (Liacouras et 
al., 2011) 
 
Fig 2.            3 
Age distribution of patients inflicted with EE. Majority of patients that are diagnosed with EE 
each year are in the age range of adults, primarily young to middle-aged adults.     (Van Rhijin, 
2012) 
 
Fig. 3.            3 
Prevalence trends across multiple cities around the world. Prevalence of EE has increased 
markedly since the 1990s, through the use of better diagnostic techniques and understanding of 
EE. (Dellon & Hirano, 2018) 
 
Fig. 4:            4 
Incidence rates of EE in multiple cities around the world. Just like prevalence rates, incidence 
rates have increased significantly since the 1990s and is expected to continue to increase. 
(Dellon & Hirano, 2018) 
v 
 
 
 
 
Fig 5.            7 
Pathways activated by TSLP binding. TSLP activates many pathways when binding to its receptor. 
Activation of STAT, MAPK, NFKBIA, and others cause an inflammatory response in both airway 
diseases and EE. (Zhong et al., 2014) 
 
Fig. 6:            8 
Electron microscopy of junctional complexes. At the apical level, tight junctions can be seen. 
Underneath the tight junctions, adherens junctions and desmosomes can be seen as well. 
(Fawcett DW, The Cell: An Atlas of Fine Structure, WB Saunders, Philadelphia, 1966, p. 367.) 
 
Fig. 7:            9 
 Barrier function proteins in adjacent cells. A. Shows junctional complexes and their interactions 
with the cytoskeleton/ basement membrane. B. Shows tight and adheren junctions mediate cell-
cell contact and interact with actin cytoskeleton. (Loxham & Davies, 2017) 
 
Fig 8:            12 
Type 2 cell immune stimuli, such as dust mite protease activity, leads to an immune response. 
Activation of receptors on the epithelium leads to release of innate pro-Th2 cytokines. (Hammad 
& Lambrecht, 2015) 
 
vi 
 
 
 
Fig 9.            19 
Changes in epithelial resistance based on various concentrations of dust mites. Dust mites 
decreased epithelial resistance at each concentration level used. The combination of dust mites 
and eosinophils lead to even greater decreases in epithelial integrity 
 
Fig 10.           22 
 Changes in epithelial resistance based on different experimental conditions applied to each 
well. Over the course of the 48 hours, decreased epithelial resistance was seen in wells 
containing EOS, TSLP EOS, and TSLP DM EOS 
 
Fig. 11           25 
 Immunofluorescence imaging of ZO-1. A) Control shows a ZO-1 present between two different 
cells B) TSLP showed ZO-1 similar to the control, with defined ZO-1 between cells C) Eosinophil: 
Decreased number of ZO-1 is signified with decreased TEER readings D) Interferon-Gamma: Had 
limited effect on TEER readings and ZO-1 is still present between esophageal cells 
 
Fig. 12            26 
Immunofluorescence imaging of ZO-1. E) Gö 6976 show tight junctions separating two 
esophageal cells F) TSLP EOS show dispersed tight junction proteins, leading to decreased 
epithelial resistance G) TSLP DM shows retained epithelial resistance, however, imaging of TSLP 
vii 
 
 
 
DM showed limited number of ZO-1 H) TSLP DM EOS: Very dispersed ZO-1 with increased 
staining by the nucleus of the cells, showing increased intracellular ZO-1 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
viii 
 
 
 
List of Abbreviations 
EE  Eosinophilic Esophagitis 
TSLP:  Thymic stromal lymphopoietin 
GERD  Gastroesophageal reflux disorder 
DM  Dust mites 
EOS  Eosinophils 
IFN-Gamma Interferon-Gamma 
Anti-TSLP TSLP synthetic Peptide 
PPI  Proton Pump Inhibitor 
 
 
 
 
 
 
 
 
 
 
ix 
 
 
 
Table of Contents 
Acknowledgments ................................................................................................................. i 
The Effect of Dust Mite extract on Esophageal Tight Junctions in Eosinophilic Esophagitis ........ ii 
List of Figures ........................................................................................................................ iv 
List of Abbreviations ........................................................................................................... viii 
Chapter 1: Introduction ........................................................................................................1 
What is Eosinophilic Esophagitis ................................................................................................ 1 
Statistics on Eosinophilic Esophagitis ......................................................................................... 2 
Gastroesophageal Reflux vs. Eosinophilic Esophagitis .............................................................. 4 
Mechanism and signaling pathways involved in Eosinophilic Esophagitis ............................... 5 
Tight Junctions ............................................................................................................................. 7 
Treatments of Eosinophilic Esophagitis ...................................................................................... 9 
Thymic stromal lymphopoietin ................................................................................................. 10 
Asthma and TSLP connections .................................................................................................. 11 
Dust mites and aeroallergens ................................................................................................... 12 
Hypothesis: ................................................................................................................................ 13 
Chapter 2: Materials and Methods ....................................................................................... 14 
Cell Culture ................................................................................................................................ 14 
Transwell Cell culture ................................................................................................................ 15 
Measuring Epithelial Integrity by Trans Epithelial Electrical Resistance (TEER) ..................... 15 
Experimental Conditions ........................................................................................................... 15 
Immunofluorescence ................................................................................................................ 16 
Microscopy ................................................................................................................................ 17 
x 
 
 
 
Statistical Analysis ..................................................................................................................... 17 
Chapter 3: Results ................................................................................................................ 18 
Determining Dust Mite Concentration ..................................................................................... 18 
Effect of Dust Mites and Eosinophils on Epithelial Resistance ................................................ 20 
ZO-1 function impaired by eosinophils and dust mites ........................................................... 23 
Chapter 4: Discussion ........................................................................................................... 27 
Bibliography ........................................................................................................................ 32 
 
1 
 
 
 
Chapter 1: Introduction 
What is Eosinophilic Esophagitis 
Eosinophilic Esophagitis (EE) is a chronic inflammatory disease of the esophagus 
effecting children and adults. EE is an allergy-mediated disease characterized by infiltration of 
eosinophils in the esophageal epithelium, which can lead to dysfunction of the esophagus (Fig 1) 
(Dellon, 2013). As a result of the increased infiltration of eosinophils into the esophagus, chronic 
inflammation occurs, which can lead to a variety of symptoms including dysphagia (food 
impaction), development of esophageal rings, linear furrows, white plaques, exudates, high 
eosinophil number, and the presence of eosinophil degranulation (Dellon, 2009, Lucendo, 2017). 
Prominent symptoms of this disorder change based on the age of the patient. If these symptoms 
are left unchecked, they will lead to esophageal remodeling and fibrosis. To be able to diagnosis 
EE in a patient, an esophageal biopsy is taken after eight weeks on a proton pump inhibitor 
(PPI). This step is used to show that gastric acid is not the cause of the inflammation. Even 
though more current studies have recognized PPI-responsive esophageal eosinophilia (PPI-REE), 
PPIs are still required in order to formally diagnosis EE. Biopsies that shows greater than 15 
eosinophils per high power field (eos/hpf) will signify EE in the patient (Hill, 2014). Currently, the 
number of people diagnosed with EE is approximately 1 in 1000 and is the number one diagnosis 
for patients that come in for complaints for food dysphagia. That number is currently expected 
to increase even with the increased knowledge of EE and better diagnosing techniques (Dellon, 
2014).  
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Statistics on Eosinophilic Esophagitis  
 EE is capable of existing in all ages, with a majority of patients being middle aged adults, 
30-50 (Fig 2), and men are being three times more likely to be diagnosed with EE compared to 
women. EE is a global disease, but it is far more prevalent in western countries, such as the 
United States and European countries due to differences in diet compared to other countries. 
(Hruz, 2014). Difficulty in diagnosing EE has made determining what the correlation between 
onset of symptoms and diagnosis of EE. According to a 2003 study conducted by Croese et al., 
patients would find strategies to alleviate EE symptoms, such as changing eating habits or 
avoiding certain foods that would aggravate EE symptoms. As a result, patients would be able to 
undergo long periods of time before diagnosis was determined, resulting in the mean time 
between patient reported onset of symptoms and diagnosis to be around 54 months (Croese, 
2003). Other studies have shown a similar correlation between onset of symptoms and delayed 
diagnoses (Hruz, 2011). By modifying diet and developing strategies to limit food dysphagia and 
or EE symptoms, patients can prolong diagnosis of EE, creating a delay in identification of the 
disease. These ongoing issues signify the difficultly in diagnosing EE. (Hruz, 2011). 
Fig. 1: Histology of normal esophagus and EE. A. Normal histology of the esophagus. B. EE biopsy 
showing infiltration of eosinophils in the epithelium. C. Shows superficial layering of surface eosinophils 
through black arrow. D. An example of an eosinophilic microabscess (Liacouras et al., 2011) 
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Fig. 3. Prevalence trends across multiple cities around the world. Prevalence of EE has increased markedly since the 
1990s, through the use of better diagnostic techniques and understanding of EE. (Dellon & Hirano, 2018) 
 
 
 
 
 
 
 
Overall, the prevalence of EE has been increasing since the 1990s, due in part of the 
increased research into EE and better diagnostic techniques to differentiate the disease from 
other related GI atopic diseases (Fig 3). In the 1980s and 90s, EE was not fully understood and as 
a result, was misdiagnosed, often confused with GERD, due to similar symptoms. Both adult and 
pediatric cases of EE have been increasing with current US adult prevalence rates of .05 to 1 
patients per 1000 inhabitants in the United States, and pediatric prevalence rates of 50.5 
patients per 10,000 inhabitants (Dellon, 2018). Which is statistically similar to pediatric 
inflammatory bowel disease (Cianferoni, 2015).  
 
 
 
 
 
 
 
Fig 2. Age distribution of patients inflicted with EE. Majority of patients that are diagnosed with EE each year are in 
the age range of adults, primarily young to middle-aged adults.     (Van Rhijin, 2012) 
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Fig. 4: Incidence rates of EE in multiple cities around the world. Just like prevalence rates, incidence rates have 
increased significantly since the 1990s and is expected to continue to increase. (Dellon & Hirano, 2018) 
 
 
 
 
 
 
 
 
 
Incidence rates of EE have also increased (Fig 4). A longitudinal study revealed incidence 
rates were 6.37 cases reported per 100,000 inhabitants during the six-year period Disease 
incidence was also shown to be 19 times higher in males compared to females (Hruz, 2014). 
Gastroesophageal Reflux vs. Eosinophilic Esophagitis 
Due to the similar symptoms between gastroesophageal reflux disease (GERD) and EE, it 
has been difficult to distinguish between the two diseases. GERD is a gastrointestinal disorder 
that can cause mucosal damage in the esophagus, oral cavity, and lungs. This is caused by 
abnormal reflux of gastric acid into the esophagus causing damage to the epithelial cells of the 
mucosa (Badillo, 2014). Multiple symptoms are similar between the two diseases. Heartburn, 
dysphagia (or food impaction), and chest pain are all commonly seen in patients with these 
conditions. Biopsies are often needed to determine the difference between the two (Molina-
Infante, 2008). Inflammation of the two diseases is induced by different stimuli. Acid reflux into 
the lower esophagus is main cause for GERD while EE inflammation is induced by antigen-
mediated inflammation that corresponds to eosinophil release of type-2 inflammatory 
mediators. Treatment of the two diseases are also distinctly different, with GERD being primarily 
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treated through the use of proton pump inhibitors (PPI) and EE being treated through topical 
corticosteroids and changes in diet. However, EE patients can also receive relief from symptoms 
through the use of PPIs, making the overlap between the diseases difficult to differentiate. EE 
and GERD are not mutually exclusive diseases. The relationship between the two diseases, along 
with the symptoms they both present, show a complex interaction and possible comorbidity 
between EE and GERD. However, researchers are still determining whether both diseases can 
coexist. Two studies have shown that about 50 percent of patients with EE had acid reflux. 
However, the number of patients that have both EE and GERD is still under debate, as there are 
inconsistent criteria in defining EE (Cheng, 2014).  
New types of diagnostic techniques are always being employed to better differentiate 
the two diseases. One such method is measuring the difference in mucosal impedance (MI) by 
measuring the degree of spongiosis or epithelial integrity. By measuring MI along various parts 
of the esophagus, EE and GERD can be distinguished from each other with great accuracy and 
through minimally invasive methods (Choksi, 2017). 
Mechanism and signaling pathways involved in Eosinophilic Esophagitis 
EE is caused when antigens from allergens bind to receptors in the mucosa of the 
esophagus. When the antigen binds the esophageal mucosa, it activates a type 2 (Th2) helper T-
cell immune response. Thymic Stromal Lymphopoietin (TSLP) is secreted from the epithelial cell 
as a result of antigen binding. TSLP is thought to be the main regulator and cause of the Th2 
reaction in EE. TSLP promotes cytokine secretion and also induces maturation of dendritic cells, 
which leads to the infiltration of CD4+ T cells and their differentiation into Th2 cells, which 
mediate activation of cytokines against allergens.  (Cianferoni, 2015). TSLP that is secreted from 
the esophageal epithelial cells will bind to TSLP receptor cells on dendritic cells, increasing the 
secretion of OX40 ligand. OX40 ligand induces CD4+ T-cells into secreting inflammatory 
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cytokines, such as interleukin (IL)-4, IL-5, and IL-13 (Shi, 2017). The binding of TSLP to TSLP 
receptors forms a complex that leads to activation of various signal transduction pathway. One 
pathway of note is the JAK/STAT pathway (Fig. 5) (Cheng, 2016). The JAK/STAT pathway is 
responsible for principal signaling for cytokines and growth factors. Activation of this pathway 
will lead to cell proliferation, differentiation, migration, and apoptosis. Inhibition of this signaling 
pathway will ultimately lead to decreases of these changes. Unwarranted activation of the 
pathway can ultimately lead to inflammation (Rawlings, 2004). TSLP will induce the 
phosphorylation of janus kinases (JAK) and lead to the activation of the kinase. The activation of 
JAK will lead to the activation of signal transducers and activators of transcription (STAT) factors, 
as well as other proteins. JAK phosphorylates a tyrosine residue leading to dimerization of STAT, 
subsequent nuclear translocation, and binding to gene promoters for the activation or inhibition 
of various target genes (Zhong, 2014). In EE, JAK will specifically phosphorylate STAT 6, which 
increases expression of eotaxin and will lead to activation esophageal epithelial cells and 
fibroblasts to secrete Eoxtaxin-3. Eoxtaxin-3 is a powerful eosinophil chemoattractant 
responsible for the migration of the inflammatory cell to the esophagus (Cheng, 2016). The 
cytotoxins secreted from the eosinophils increase the permeability of esophagus, weakening the 
tight junctions and dilate intercellular spaces. Due to the inflammation caused by the cytokines, 
fibrotic changes occur, causing the symptoms seen within EE patients (Cheng, 2014). 
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Fig 5. Pathways activated by TSLP binding. TSLP activates many pathways when binding to its receptor. 
Activation of STAT, MAPK, NFKBIA, and others cause an inflammatory response in both airway diseases and EE. 
(Zhong et al., 2014) 
 
 
 
 
 
 
 
 
 
 
 
 
Tight Junctions 
Tight junctions (Fig 6) are important to maintain barrier function between the internal 
and external environments. Tight junctions, along with adherens junctions, connect epithelial 
cells together, forming a physical barrier and sealing off of the paracellular space (Fig 7) 
(Abdulnour-Nakhoul, 2013). In epithelial cells, they connect adjacent cells to one another and 
regulate the passage of foreign molecules that come into contact with the cells. Tight are found 
at the most apical section between two adjacent cells. Tight junctions are made up of 
transmembrane and intracellular proteins, which link up with the actin cytoskeleton. The 
function of tight junctions is to seal adjacent cells and regulate paracellular passages of 
molecules. Two major proteins that make up tight junctions are occludins and claudins. 
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Occludins are transmembrane proteins that regulate passage of macromolecules through the 
tight junction. Claudins, another transmembrane protein, are more specific and give tight 
junctions size and charge selective properties to regulate macromolecules that enter 
paracellularly (Loxham, 2017). Occludins and claudins are anchored intracellularly by cell 
junction complexes known as zonula occludens. Zonula occludens are scaffold proteins that 
connect junctional protein complexes to the cytoskeleton. (Steelant, 2016). Additional junctional 
protein complexes are present, such as adherens junctions and desmosomes are found along 
the basolateral cell surface. These junction complexes provide adhesion forces that help 
maintain epithelial integrity (Loxham, 2017). In EE, studies have shown that these tight junctions 
and adherens junctions are affected; expression of E-cadherin and claudin-1 proteins decreased 
while occludins expression increased. Decreases in claudin-1 expression impairs tight junction 
barrier function. The significance of increased expression of occludins was not determined 
(Abdulnour-Nakhoul, 2013).  
 
 
 
 
 
 
 
 
Fig. 6: Electron microscopy of junctional complexes. At the apical level, tight junctions can be 
seen. Underneath the tight junctions, adherens junctions and desmosomes can be seen as well. 
(Fawcett DW, The Cell: An Atlas of Fine Structure, WB Saunders, Philadelphia, 1966, p. 367.) 
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Treatments of Eosinophilic Esophagitis 
Current treatment of EE typically involves dietary restrictions. The use of elimination 
diets has been used with some success. The treatment revolves around systematically removing 
certain foods known to cause an allergic response or inflammation. However, despite the 
success of these diets, they are difficult to maintain for long periods of time. Studies have found 
poor adherence to these diets, with under 50% of patients maintaining the lifestyle change 
(Kliewer, 2017). The difficulty in maintaining these diets is likely due to financial and logistical 
barriers. These ultimately limit the success of this treatment despite the increased resolution of 
symptoms. 
Topical corticosteroids are also used to treat inflammatory symptoms of. Steroids 
decreased the amount of spongiosis and increased intracellular fluid by strengthening the tight 
Fig. 7: Barrier function proteins in adjacent cells. A. Shows junctional complexes and their 
interactions with the cytoskeleton/ basement membrane. B. Shows tight and adheren junctions 
mediate cell-cell contact and interact with actin cytoskeleton. (Loxham & Davies, 2017) 
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junctions in the esophagus. Specifically, filaggrin levels are restored in treated EE patients, as 
untreated EE patients have a decrease in the protein. With the increase of filaggrin, spongiosis is 
decreased, preventing leakage between the tight junctions (Katzka, 2014). While both diet and 
corticosteroid treatments lead to an initial decrease in the symptoms of EE, combination 
treatment of both diet and steroids has been shown to significantly decrease relapse of EE 
(Reed, 2018). 
Despite the success of these treatments, they have been limited in the success of 
treating EE completely. The main issue with these treatments are that they are nonspecific. 
Targeting specific immune pathways may provide treatment options to help resolve EE 
symptoms and treat the disease more effectively. TSLP is one such target. Initial studies 
conducted have shown that by neutralizing TSLP, symptoms of EE decreased as well as 
resolution of EE histologically (Noti, 2013). 
Thymic stromal lymphopoietin  
TSLP is an inflammatory interleukin (IL)-7-like cytokine that is secreted from multiple cell 
types, such as epithelial cells, epithelial keratinocytes, dendritic cells, and mast cells in response 
to antigen binding. TSLP has many connections to many types of allergic disorders, such asthma, 
atopic dermatitis, allergic rhinitis, and EE. Two isoforms, long and short, of TSLP have been 
described, each with different effects in the body. The two types of TSLP have protective and 
deleterious effects based on which one is secreted. Long form TSLP leads to deleterious effects 
via barrier dysfunction and inflammatory factors. The short form of TSLP leads to protective 
effects of barrier function and is the predominate form of TSLP in healthy individuals. In EE, long 
form TSLP is the primary form secreted due to the increase of inflammatory factors caused by 
the disorder (Dong, 2016). TSLP is produced by epithelial cells in the esophagus, promoting 
migration of immune cells to the area. TSLP binds to TSLP receptors on dendritic cells (DC), 
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producing a Th-2 favorable environment (Ito, 2012). TSLP will activate multiple signal 
transduction pathways as a result of binding to the TSLP receptor in DCs, such as the JAK/STAT 
pathway. As a result of TSLP binding, DCs secrete more OX40 ligand, which regulates DC to T-cell 
interaction, and initiate the Th2 cellular response.  OX40 ligand will prime CD4+ T cells to secrete 
inflammatory cytokines IL-4, 5, and 13, along with tumor necrosis factor alpha (Shi, 2017).  
Asthma and TSLP connections 
Due to inflammation caused by Th2 cells, EE has pathologic connections with asthma 
and related disorders, such as allergic rhinitis and atopic dermatitis. In both diseases, Th-2 
inflammation causes structural damage to each of the relevant pathways. In EE, esophageal 
epithelium is affected and allows migration of eosinophils to the esophagus. This has parallels to 
asthma, in which airway remodeling occurs due to the inflammation caused by a related Th2 
reaction. Chronic inflammation in both cases causes structural changes in their associated 
organs (Nhu, 2017). Coexistence or comorbidity of EE and Asthma does exist as studies have 
found that 23-37.5 percent of patients with EE also have asthma as well (Durrani, 2018). EE 
patients are also more likely to have asthma than control patients (Gonzalez-Cervera, 2017).  
Treatment options for both of these diseases exist as well. Studies on the use of anti-TSLP has 
also been seen to increase resolution of symptoms of both diseases by limiting the amount of 
type 2 inflammation caused by the effects TSLP on inflammatory cells. By neutralizing TSLP, 
chronic inflammation is inhibited, preventing airway and esophageal remodeling in asthma and 
EE respectively (Chen, 2013). 
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Fig 8: Type 2 cell immune stimuli, such as dust mite protease activity, leads to an immune response. Activation 
of receptors on the epithelium leads to release of innate pro-Th2 cytokines. (Hammad & Lambrecht, 2015) 
 
 
 
 
 
 
 
 
 
Dust mites and aeroallergens 
Dust mites and other aeroallergens have been found to promote tight junction barrier 
dysfunction (Fig 8). Dust mites are an environmental allergen that will produce a Th2 response, 
typically causing chronic inflammation. Inflammation caused by exposure to aeroallergens, leads 
to structural remodeling and alterations to the epithelial cells as well (Chen, 2013). A study 
looking at the effects of dust mites on patients with allergic rhinitis determined that tight 
junctions were affected, causing barrier dysfunction. The application of dust mites to the nasal 
epithelium resulted in tight junctions becoming more permeable, with increased exposure to 
dust mites. Protein and mRNA levels are markedly decreased compared to other tight junction 
proteins, specifically occludins and zonula occludens-1. Overall, dust mites have a significant 
impact on barrier function in airway pathway diseases (Steelant, 2016). Exposure of dust mites 
to the epithelial cells has also been shown to increase the amount of TSLP secreted due to the 
damage they cause to the epithelium. Like other types of respiratory diseases associated with 
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TSLP, dust mites will lead to overexpression of TSLP, and an increased cascade of inflammatory 
factors (Hu, 2017).  
Research has recently investigated the role of aeroallergens and EE. A 2003 case study 
has shown that a patient with EE had symptoms become more severe during pollen season 
compared to winter seasons. The patient had no food allergies and no other significant medical 
issues other than asthma. Inflammation become significantly worse during the pollen seasons, 
with biopsies during this period showing increased inflammation response and symptoms. 
During the winter months, there was less inflammation caused by eosinophils. This case study 
hypothesized that aeroallergens have a role in EE. (Fogg, 2003) More recent studies have found 
similar results in pediatric patients, with increased esophageal eosinophilia during certain 
seasons depending on the season of the aeroallergen (Ram, 2015). A retrospective chart review 
of patients with EE also showed a greater number of patients with environmental allergies (58%) 
compared to food allergies (28%) (Patel, 2014). Other case studies have shown that aeroallergen 
sensitization might also increase with age, as older patients with EE are typically seen with only 
aeroallergens and no food allergies compared to pediatric patients (Sugnanam, 2007). These 
studies show that aeroallergens might play a greater role in EE than previously thought. 
Hypothesis:  
Aeroallergens, such as dust mites,  impact the development and severity of eosinophilic 
esophagitis through thymic stromal lymphopoietin (TSLP) signaling pathway. 
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Chapter 2: Materials and Methods 
Cell Culture 
EPC2 cells, a gift from Hiroshi Nakagawa at the University of Pennsylvania, were 
harvested through a 55-year-old male who suffered from Barrett’s esophagus. The cells were 
collected from a morphological normal site with testing concluding that they were normal and 
had no traces of cancer. Cells were cultured as monolayers in a Corning filtered cap chambered 
flask. Esophageal cells were grown in Keratinocyte-SFM medium supplemented with Bovine 
Pituitary Extract and human recombinant epidermal growth factor (Invitrogen). Cells were 
grown to 80% confluency, at which they were passed to another flask for continued growth or 
transferred to a Transwell epithelium plate for experimentation. Cells were passed by adding 5 
mL of trypsin-EDTA to the flask to unadhered the cells from the flask surface. After incubations 
period of 5 minutes, soybean trypsin inhibitor (STI) (SigmaT9128) was added to deactivate to 
trypsin since EPC2 cells are sensitive to trypsin. The contents of the flask are centrifuged for 3 
minutes at 1000 rpm at 40C. The cells are resuspended in specific media to needed cell 
concentration. 
Eosinophils were cultured as well, cells were taken from the cell line AML 
14.3D10/CCCKR3 Clone 16 (ATCC CRL-12079). These cells were acquired from the peripheral 
blood. Cells were stored in a nitrogen-gas freezer until they were thawed and used. Eosinophils 
were grown in RPMI 1640 Gibco (A10-491) media supplemented with .05 mM 2-
mercaptoethanol, 2 mg/mL G418, 1 mM sodium pyruvate, 2 mM L-Glutamate, and 10% FBS. 
Flasks were incubated at 37oC to allow for growth.  
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Transwell Cell culture 
For experimentation, esophageal cells were placed in Corning™ Transwell Multiple Well 
Plate with Permeable Polycarbonate Membrane Inserts. Inserts separate the well into two 
compartments to signify a basolateral and luminal compartment. Esophageal cells were placed 
inside the inserts (Luminal compartment) with media (200 uL) and 1 mL esophageal media was 
placed inside the bottom of each well (basolateral compartment). Plates were placed in a 37oC 
incubator to allow esophageal cells to grow to confluence and form monolayer. Cell media was 
changed every 2 days to allow for continued growth. 
Measuring Epithelial Integrity by Trans Epithelial Electrical Resistance (TEER) 
Integrity of the epithelial membrane electrical resistance was measured using the 
Millicell ERS-2 Voltohmmeter to measure transepithelial electrical resistance (TEER). 
Measurements were acquired at 24 hours after addition of eosinophils and 1, 3, 6, 24, and 48-
hour time periods. The probe was sanitized with 70 percent ethanol and calibrated using 
esophageal media. The probe was then placed in the transwell, with one side of the probe in the 
luminal compartment and the other in the basal compartment. Readings were allowed to 
stabilize before being recorded. All readings were recorded in Ohms.  
Experimental Conditions 
Once esophageal cells were confluent on the epithelial plates, experimental conditions 
could be applied to each of the wells. The cells in each well were measured by TEER prior to 
addition of experimental conditions. Eosinophils (100 eos/ml/ per well) were then added to 
basal compartment of specific wells and were allowed 24 hours to equilibrate. Eosinophil 
concentration were determined by using the TC20 automatic cell counter (Biorad). Eosinophil 
concentration was kept low to limit their effect on the epithelium resistance. Cell TEER was 
measured again after the 24-hour period and other experimental conditions were then added to 
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each well.  All conditions were applied to the basolateral compartments of each well. Conditions 
were added individually to each cell or in combination with another experimental condition. 
TSLP synthetic peptide (Invitrogen, PEP-049) (20 ng/mL), house dust mites (1 ug/mL), Interferon-
Gamma (ThermoFisher Scientific) (100 ug/mL), and Gö 6976 (Cayman Chemical) (100 ug/mL), a 
PKC inhibitor, to strengthen tight junctions, were used in each experiment. Each condition was 
repeated at least twice with anti-TSLP, anti-TSLP and eosinophils (anti-TSLP EOS), TSLP and dust 
mites (TSLP DM), and TSLP, dust mites and eosinophils (TSLP DM EOS), run in triplet or more. 
TSLP synthetic peptide or anti-TSLP, interferon-gamma (IFN-G), and Gö 6976 (G0) was added 
after measurement of 24 hours after addition of eosinophils and allowed to incubate three 
hours. After the three hours, dust mites were then added to the appropriate wells. Once the 
conditions were applied, cells were stored in an incubator at 370C until measurements were 
conducted. Plates were allowed to equilibrate for 30 minutes before they were measured. TEER 
measurements were taken at 24 hours after added eosinophils, 1, 3, 6, 24, and 48 hours. 
Immunofluorescence 
Changes in tight junction protein, ZO-1, were observed via immunofluorescence. 
Imaging of each experimental condition was taken from eight different plates. Once 
experimentation was completed, each well was gently washed 3-5x with PBS. The cells were 
then placed in paraformaldehyde for 10 minutes. The wells were then rinsed again with 3-5x 
phosphate-buffered saline (PBS) and blocking solution was placed in each for 15 minutes. 
Blocking solution was made from 5% bovine serum albumin (Fisher Scientific), sodium azide 
(Fisher scientific), triton x-100 (Fisher Scientific), and 1x PBS. Cells were rinsed 3-5 times with 
PBS and then placed in the primary antibody Rabbit anti ZO-1 (Thermo Fisher Scientific, 
#617300).  The cells and antibody were allowed to incubate for 1 hour. The primary antibody 
was then rinsed off lightly with PBS and the secondary antibody, Alexa 488 Goat anti-rabbit 
17 
 
 
 
(Thermo Fisher Scientific) was applied to the cells and allowed to incubate for 1 hour at room 
temperature. Once the secondary anti-body incubated, the cells were lightly washed with PBS 
and prepped for transfer to a microscope slide. The cells were cut away from the wells with a 
scalpel and placed onto the slide. Pro-Long Gold antifade with DAPI (Invitrogen) applied to the 
cells and a microscope slide cover sealed the cell sample. The slides were then stored in at 4oC 
until they could be analyzed through microscopy. 
Microscopy 
Esophageal cells were observed through the Zeiss Axio Observer Z1 Research 
Microscope. Images were captured with the Axiocam 105 Digital Color camera via the ZEN 2.3 
Pro imaging software. After images were captured, Adobe Photoshop was used for post 
processing to adjust contrast and brightness of the images to highlight ZO-1. 
Statistical Analysis 
Statistical analysis was completed using Graphpad Prism 7 software. Data was analyzed 
using a one-way ANOVA test to compare significant differences among each of the experimental 
conditions. T-tests were also used to compare conditions to the control. The data was 
considered significant if p-values were less than 0.05. 
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Chapter 3: Results 
Determining Dust Mite Concentration 
Dust mite concentration was based on initial experimental information prior to the 
project starting. Five different dust mite concentrations were used to determine the dosage of 
dust mites for the project’s experiments. The concentrations used in this experiment were 1 
ul/mL, 10 ug/mL, 25 ug/mL, 50 ug/mL, and 100 ug/mL. Measurements were taken over a 24-
hour period. The distribution obtained at each concentration of dust mites suggest that dust 
mites trigger a response in esophageal cells even at a low dosage. As seen in Fig. 9, over the 
course of 24-hour period, addition of dust mites leads to decreased epithelial resistance with 
exception at hour 0. Hour 0 increased in resistance due to the added esophageal media added 
when dust mites were added to the wells. All concentrations of dust mites show a decrease in 
epithelial resistance after 1 hour of application when compared to the control. After the 24 
hours, dust mites extract caused a decrease of epithelial resistance by 61 ohms in 1ug/mL, 80 
ohms in 10 ug/mL, 58 ohms in 25 ug/mL, 74.33 ohms in 50 ug/mL and 100.5 ohms in 100 ug/mL. 
The application of both eosinophils and dust mites lead to a further decrease in resistance (Fig 9 
A-E). By comparing the mean differences between DM and DM EOS after 24 hours, DM EOS lead 
to a 2 times epithelial resistance decrease when compared to dust mites alone (Fig 9 A-E). This 
suggest that dust mites cause an additive effect when applied to eosinophils or they can cause 
damage to the epithelium directly, independent of the actions of eosinophils. Though only 50 
ug/mL DM and 100 ug/mL DM EOS showed significance by ANOVA, decreases caused by DM and 
DM EOS is seen at all concentrations. Due to the response and trends observed from the data, 
the 1 ug/mL dust mite concentration was chosen for the experiment. This low dosage was 
selected as the minimal threshold response to limit the number of confounding variables. 
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Fig 9. Changes in epithelial resistance based on various concentrations of dust mites (A-D). Dust mites decreased 
epithelial resistance at each concentration level used. The combination of dust mites and eosinophils lead to even 
greater decreases in epithelial integrity. 
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Effect of Dust Mites and Eosinophils on Epithelial Resistance 
Based on the trends of decreased epithelial resistance seen in prior experiments by dust 
mites and eosinophils, we sought to see if application of anti-TSLP would counteract the effects 
of dust mites and eosinophils. Throughout the experiment, there were changes seen based on 
the conditions applied to the esophageal cells. During the first and third hours of the experiment 
on each plate, there were no changes seen in any of the experimental conditions compared to 
the control. Alterations in TEER begin to occur at six-hours. Compared to the control, there was 
a significant decrease in epithelial resistance in the anti-TSLP DM EOS treated cells (Fig. 10C, 
p<.05). The difference in mean between this condition and the control was approximately 15 
ohms. At the 24-hour condition, anti-TSLP EOS along with anti-TSLP DM EOS were seen to 
significantly decrease epithelial resistance compared to the control (Figure 10D, p<.05). TSLP 
EOS mean decrease compared to the control was 44.3 ohms. Anti-TSLP DM EOS had a mean 
decrease of 55.72 ohms compared to the control. At the 48-hour measurement, three different 
condition saw significant changes compared to the control. Anti-TSLP EOS and anti-TSLP DM EOS 
saw significant decreases in epithelial resistance, while G0 saw a significant increase in 
resistance, which was expected (Fig 10E, p<.05). anti-TSLP EOS decreased by a mean of 28.65 
ohms and anti-TSLP DM EOS decreased by a mean of 48.16 ohms. Gö 6976, was the only 
condition to increase epithelial resistance, increased by a mean of 38.5 compared to the control. 
Gö 6976 was also used as an additional control as well, by strengthening tight junction function. 
The Gö 6976 control was used to ensure esophageal cells were normal and were not mutated 
through multiple passages of cells during cell culture. Gö 6976 works by being a PKC inhibitor, 
preventing activation of the JAK STAT pathway. While not significant, the graphs show an 
additional decrease in resistance when added to the anti-TSLP EOS condition compared to anti-
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TSLP EOS alone. Application of dust mites also lead to a decrease in epithelial resistance as well 
as seen in Fig. 9. 
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Fig 10. Changes in epithelial resistance based on different experimental conditions applied to each well (A-
E). Over the course of the 48 hours, decreased epithelial resistance was seen in wells containing EOS, anti-
TSLP EOS, and anti-TSLP DM EOS 
 
Anti-TSLP: 20 ng/mL 
Eosinophil (EOS): 100 eos/mL/well 
Dust mite (DM): 1ug/mL  
Gö 6976 (G0): 100 ug/ mL 
Interferon-Gamma (IFN-Gamma): 100 ug/mL 
* = Data is significant compared to the control 
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ZO-1 function impaired by eosinophils and dust mites 
After seeing the decreased epithelium values for wells containing dust mites and 
eosinophils, tight junctions were imaged to determine dust mites and eosinophils effects on 
these proteins. Figure 11 shows differences between the control, Eosinophils, anti-TSLP, and 
interferon-gamma. The control shows intact tight junctions with ZO-1 forming a clear line 
between two adjacent cells. The nuclei of the cells are shown through the use of DAPI. TSLP 
shows a similar look to the control in Figure 11B. anti-TSLP slides had TSLP synthetic peptide 
added to the well. Tight junctions remained intact as well. Figure 11C shows wells applied with 
eosinophils. Tight junctions were decreased due to the cytotoxins released from eosinophils. As 
a result, immunofluorescence of ZO-1 was diminished compared to the control. Figure 12 shows 
the other four conditions used in the experiment. G0 was a control that would strengthen tight 
junctions. As the image shows, ZO-1 is very prominently displayed in the microscope slide with 
the proteins appearing between two esophageal cells. This was expected due to the increase in 
tight junction function that G0 adds. Imaging of TSLP DM shows multiple ZO-1 protein staining. 
Anti-TSLP limited the affect dust mites cause on tight junction proteins. This phenomenon was 
also seen in the epithelial resistance as well. In figure 12G, anti-TSLP EOS lead to a decrease in 
the amount of ZO-1 between esophageal cells. As seen in the image, very few ZO-1 proteins 
showed up and epithelial resistance confirms the decrease in tight junction proteins as seen in 
Fig. 10. Lastly, anti-TSLP DM EOS showed the most major changes in tight junction proteins. 
Large segments of the image show many ZO-1 proteins throughout the imaged area. Many of 
these proteins are close to the nuclei of esophageal cells as shown by DAPI. There is also no 
discernable pattern to ZO-1 proteins around the nuclei and not clear barrier is seen between 
esophageal cells. Each of these images indicate the changes to tight junction proteins under 
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different experimental conditions. Most of the changes seen are conditions that lead to a 
decrease in epithelial cell resistance, causing leaky tight junction barriers. 
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Fig. 11 Immunofluorescence imaging of ZO-1. A) Control shows a ZO-1 present between two different cells B) TSLP 
showed ZO-1 similar to the control, with defined ZO-1 between cells C) Eosinophil: Decreased number of ZO-1 is 
signified with decreased TEER readings D) Interferon-Gamma: Had limited effect on TEER readings and ZO-1 is still 
present between esophageal cells. Tight junction protein ZO-1 in green and esophageal cell nuclei shown in blue.   
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Fig. 12 Immunofluorescence imaging of ZO-1. E) Gö 6976 show tight junctions separating two esophageal cells F) 
anti-TSLP EOS show dispersed tight junction proteins, leading to decreased epithelial resistance G) anti-TSLP DM 
shows retained epithelial resistance, however, imaging of anti-TSLP DM showed limited number of ZO-1 H) anti-
TSLP DM EOS: Very dispersed ZO-1 with increased staining by the nucleus of the cells, showing increased 
intracellular ZO-1. Tight junction protein ZO-1 in green and esophageal cell nuclei shown in blue.   
27 
 
 
 
Chapter 4: Discussion 
In Eosinophilic Esophagitis, chronic inflammation leads to esophageal restructuring, 
causing eosinophil infiltration and tight junction disorder. Through experiments conducted prior 
and during the project, addition of dust mite extract to esophageal cells lead to a decrease in 
epithelial resistance. Every concentration level of dust mite extract lead to a decrease in 
resistance starting at 1 hour. The concentration of dust mites chosen was based on the trends 
seen in the lowest concentration and to determine the lowest dosage of dust mites that causes 
a response in esophageal cells. Dust mites can cause tight junction dysfunction by two different 
process, protease or receptor-based activity. These two pathways can lead to a decrease in 
epithelial resistance. Dust mite’s interaction with eosinophils also increases the magnitude of 
dysfunction as well, with greater decreases in resistance. 
Based on the experiment results, dust mite activity is inhibited with the addition of an 
anti-TSLP compound. Figure 9 shows the TSLP DM condition throughout the 48-hour period. 
With the application of anti-TSLP, dust mites did not exhibit a negative effect on epithelial 
resistance. This might suggest that dust mites activate esophageal cells through a receptor 
mediated response cause to secrete TSLP instead of causing protease activity (Hammad, 2015). 
Adding anti-TSLP to dust mites will inhibit the effect of TSLP on esophageal cells a counteract the 
response caused by dust mites. This is largely seen when comparing the dust mite only response 
in esophageal cells. When dust mites are the only condition added to the esophageal cells, 
epithelial resistance decreased with prolonged exposure to dust mites. When cells were 
pretreated with anti-TSLP and dust mites were applied to the cells, the epithelial resistance of 
the cells were not significantly different from the control. This might suggest that protease 
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activity of dust mites is not effective in esophageal cells and only receptor mediated pathways 
are activated when dust mites are applied to the cells. 
There is also an interesting interaction between dust mites and eosinophils that 
enhances the disruption of tight junctions in the esophagus. When eosinophils were added to 
the wells with esophageal cells, tight junction dysfunction occurred, leading to a decrease in the 
epithelial resistance. This response is expected due to inflammatory factors and cytotoxins that 
are released from eosinophils leads to barrier disruption and the cells become leakier. When 
anti-TSLP is added to this is added to eosinophils, there is no effect on eosinophil function and 
epithelial resistance remains decreased by the same level as eosinophils alone. This suggests 
that anti-TSLP does not limit stop eosinophils from degranulation and releasing factors that lead 
to tight junction disruption. However, other studies have suggested the opposite, with 
decreased eosinophil effect with the application of anti-TSLP antibodies (Gauvreau, 2014). TSLP 
is the main regulator of EE and will lead to infiltration of eosinophils to esophagus. However, 
TSLP does not have an effect on eosinophils once they have already infiltrated the epithelium, 
so anti-TSLP will not stop disruption from occurring from eosinophils. Lastly, when dust mites 
are added to the wells containing anti-TSLP and eosinophils, it leads to a greater decrease in 
epithelial resistance. It suggests that dust mites and eosinophils interact with each other to lead 
to further disruption compared when these two are separate. Dust mites or other similar 
aeroallergens might cause eosinophils to increase the secretions of cytotoxins and lead to 
greater degranulation of eosinophils. As a result, tight junctions were further affected as seen in 
imaging. A 2007 study shows that dust mites cause activation of eosinophils by binding to the 
formyl peptide receptor (FPR) and formyl peptide receptor-like 1 (FPRL1). When dust mites bind 
to these receptors, they cause activation of eosinophils and cause degranulation (Svensson, 
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2007). This process might explain why the combination of eosinophils and dust mites leads to 
greater decreases in epithelial resistance and disruption of tight junctions. 
Limitations and issues did arise during the experiment that should be noted. Growth on 
the epithelial plates was difficult throughout the project. After the cells were placed on the 
transwell plates, difficulties growing a monolayer on the inserts were encountered. As the data 
shows, there were decreased epithelial resistance readings in each of the wells, with an average 
of 200 Ohms or lower. A lower passage cells of the same cell line was used to try to combat the 
issue, however, it was unsuccessful in raising the epithelial resistance of the esophageal cells. 
Lower passage cells are at less risk to undergo mutation or differentiation.  Cells that undergo 
high number of passages can change the cell characteristics over time. Using lower passage cells 
ensured that cells were not affected by alterations in cell function, decreasing TEER (Briske-
Anderson, 1997). Different bottles of esophageal media were also used to determine if there 
were any contamination issues occurring that were inhibiting the growth of the cells. Cells were 
also allowed to grow as long as needed to ensure the monolayer formed on the transwell 
inserts. However, despite these strategies to increase epithelial resistance in esophageal cells, 
resistance remained low. As a result, trends and significance of the data might be impacted the 
diminished cell resistance, as well as imaging of tight junction proteins. This was especially seen 
during the imaging of ZO-1. With less esophageal cells forming a monolayer, less tight junction 
proteins were seen when cells were imaged. This made it difficult to determine changes in tight 
junction presence as most of the barriers between cells were already leaky, caused by the 
decrease in cells. 
 Dosage of anti-TSLP might have had an effect on experimental results as well. A dosage 
was based on a previous study for allergic asthma. Studies using anti-TSLP in airway related 
diseases, have shown a decrease in tight junction dysfunction with the addition of anti-TSLP. 
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Based on the results, anti-TSLP was effective in preserving epithelial resistance at the 
concentration of 20 ug/mL. Despite the success of anti-TSLP stopping the action of dust mites, 
more experiments need to be conducted to learn the effective concentrations of anti-TSLP to 
dust mites. This would give a better idea on how anti-TSLP affects dust mite function and 
provide the amount needed to maintain epithelial resistance.  
 Issues with staining for immunofluorescence also occurred. Staining was not optimal for 
showing tight junction dysfunction. Problems in immunofluorescence could have come from 
multiple areas. Two issues that present themselves as the most logical areas is in growth of the 
cells and washing the cells during the staining protocol.  As mentioned previously, there were 
issues involved in raising the epithelial resistance on the transwell cell culture plates. Since the 
cells were leaky at the start, the number of tight junction proteins might have been reduced 
from the start. This would lead to decreased number of ZO-1 in the stain making it difficult to 
demonstrate how tight junctions were affected. Another possible area is the washing of cells 
during the staining process. The antibody staining for immunofluorescence protocol calls for 
multiple washes throughout the process to remove excess antibody and prepare it for the next 
step. During this process, cells might have washed away during removal of the PBS wash. This 
would lead to less cells available and less ZO-1 for the primary antibody to bind to. Both of these 
possibilities led to poor imaging of ZO-1. 
  Future studies should continue into looking at the association between aeroallergens 
and EE. As of today, environmental allergies remain more controversial as a cause for EE than 
food allergies. More research as to look at the various environmental allergies and identify 
mechanisms lead to EE. Other treatment options could also focus on using JAK inhibitors as well. 
Since TSLP activates the JAK/STAT pathway, focusing on this pathway could lead to a decrease in 
inflammation factors and chemotaxis of eosinophils. Current JAK inhibitors are currently used to 
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address inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel 
disease (Schwartz, 2017). Since eosinophilic esophagitis is known to activate this pathway to 
lead to eosinophil attraction and inflammation in the esophagus, JAK inhibitors could become a 
possible treatment option for patients. Looking at the mechanisms and treatments of EE will 
lead to further understanding of how EE works and ways to fully combat the issues that EE 
presents. 
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